William G. Kraybill

Surgical Oncology
300 W 10th Ave
Columbus, OH 43210

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.

Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.

Journal: JAMA oncology
Published: March 30, 2023

Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation.

Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation.

Journal: Sarcoma
Published: September 03, 2017

A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.

A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: December 01, 2015

Contemporary approaches to sarcoma.

Contemporary approaches to sarcoma.

Journal: Journal of surgical oncology
Published: December 02, 2014

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Journal: The New England journal of medicine
Published: February 14, 2014

miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR.

miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR.

Journal: Science signaling
Published: August 01, 2013

The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas.

The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 01, 2012

Prognostic factors and staging for soft tissue sarcomas: an update.

Prognostic factors and staging for soft tissue sarcomas: an update.

Journal: Surgical oncology clinics of North America
Published: February 28, 2012

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330.

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330.

Journal: Sarcoma
Published: November 28, 2011
Showing 1-9 of 9

Last Updated: 09/26/2026